Nosocomial Outbreak of Infection With Pan-Drug-Resistant Acinetobacter baumannii in a Tertiary Care University Hospital

被引:167
作者
Valencia, Raquel [1 ,5 ]
Arroyo, Luis A. [2 ]
Conde, Manuel [1 ,5 ]
Aldana, Josefa M. [1 ]
Torres, Maria-Jose [6 ]
Fernandez-Cuenca, Felipe [6 ]
Garnacho-Montero, Jose [3 ]
Cisneros, Jose M. [4 ]
Ortiz, Carlos [3 ]
Pachon, Jeronimo [4 ,7 ]
Aznar, Javier [2 ,6 ]
机构
[1] Virgen del Rocio Univ Hosp, Prevent Med & Publ Hlth Serv, Seville, Spain
[2] Virgen del Rocio Univ Hosp, Clin Microbiol Serv, Seville, Spain
[3] Virgen del Rocio Univ Hosp, Intens Care Serv, Seville, Spain
[4] Virgen del Rocio Univ Hosp, Infect Dis Serv, Seville, Spain
[5] Univ Seville, Dept Prevent Med, Seville, Spain
[6] Univ Seville, Dept Microbiol, Seville, Spain
[7] Univ Seville, Dept Med, Seville, Spain
关键词
IN-VITRO ACTIVITY; POLYMYXIN-B; ANTIMICROBIAL SUSCEPTIBILITY; CDC DEFINITIONS; COLISTIN; EPIDEMIOLOGY; ACQUISITION; SURVIVAL; SPREAD; PCR;
D O I
10.1086/595977
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE. To describe what is, to our knowledge, the first nosocomial outbreak of infection with pan-drug-resistant ( including colistin-resistant) Acinetobacter baumannii, to determine the risk factors associated with these types of infections, and to determine their clinical impact. DESIGN. Nested case-control cohort study and a clinical-microbiological study. SETTING. A 1,521-bed tertiary care university hospital in Seville, Spain. PATIENTS. Case patients were inpatients who had a pan-drug-resistant A. baumannii isolate recovered from a clinical or surveillance sample obtained at least 48 hours after admission to an intensive care unit (ICU) during the time of the epidemic outbreak. Control patients were patients who were admitted to any of the "boxes" (ie, rooms that partition off a distinct area for a patient's bed and the equipment needed to care for the patient) of an ICU for at least 48 hours during the time of the epidemic outbreak. RESULTS. All the clinical isolates had similar antibiotic susceptibility patterns ( ie, they were resistant to all the antibiotics tested, including colistin), and, on the basis of repetitive extragenic palindromic-polymerase chain reaction, it was determined that all of them were of the same clone. The previous use of quinolones and glycopeptides and an ICU stay were associated with the acquisition of infection or colonization with pan-drug-resistant A. baumannii. To control this outbreak, we implemented the following multicomponent intervention program: the performance of environmental decontamination of the ICUs involved, an environmental survey, a revision of cleaning protocols, active surveillance for colonization with pan-drug-resistant A. baumannii, educational programs for the staff, and the display of posters that illustrate contact isolation measures and antimicrobial use recommendations. CONCLUSIONS. We were not able to identify the common source for these cases of infection, but the adopted measures have proven to be effective at controlling the outbreak.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 41 条
[1]   In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak [J].
Appleman, MD ;
Belzberg, H ;
Citron, DM ;
Heseltine, PNR ;
Yellin, AE ;
Murray, J ;
Berne, TV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) :1035-1040
[2]   Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii [J].
Arroyo, LA ;
García-Curiel, A ;
Pachón-Ibañez, ME ;
Llanos, AC ;
Ruiz, M ;
Pachón, J ;
Aznar, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (02) :903-905
[3]   Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients [J].
Ayats, J ;
Corbella, X ;
Ardanuy, C ;
Dominguez, MA ;
Ricart, A ;
Ariza, J ;
Martin, R ;
Linares, J .
JOURNAL OF HOSPITAL INFECTION, 1997, 37 (04) :287-295
[4]   Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].
BergogneBerezin, E ;
Towner, KJ .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+
[5]   Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients:: a matched cohort study [J].
Blot, S ;
Vandewoude, K ;
Colardyn, F .
INTENSIVE CARE MEDICINE, 2003, 29 (03) :471-475
[6]   A reassessment of the in-vitro activity of colistin sulphomethate sodium [J].
Catchpole, CR ;
Andrews, JM ;
Brenwald, N ;
Wise, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (02) :255-260
[7]   Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain:: a nationwide study [J].
Cisneros, JM ;
Rodríguez-Baño, J ;
Fernández-Cuenca, F ;
Ribera, A ;
Vila, J ;
Pascual, A ;
Martínez-Martínez, L ;
Bou, G ;
Pachón, J .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (11) :874-879
[8]  
CLSI, 2006, informational supplement M100-S16, V26
[9]   Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii [J].
Corbella, X ;
Montero, A ;
Pujol, M ;
Domínguez, MA ;
Ayats, J ;
Argerich, MJ ;
Garrigosa, F ;
Ariza, J ;
Gudiol, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (11) :4086-4095
[10]   An outbreak of Acinetobacter baumannii:: The importance of cross-transmission [J].
D'Agata, EMC ;
Thayer, V ;
Schaffner, W .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2000, 21 (09) :588-591